Creo Medical Group PLC 1RC.SG Stock
Creo Medical Group PLC Price Chart
Creo Medical Group PLC 1RC.SG Financial and Trading Overview
Creo Medical Group PLC stock price | 0.39 EUR |
Previous Close | 0.31 EUR |
Open | 0.35 EUR |
Bid | 0.37 EUR x 0 |
Ask | 0.42 EUR x 0 |
Day's Range | 0.35 - 0.35 EUR |
52 Week Range | 0.2 - 1.08 EUR |
Volume | 0 EUR |
Avg. Volume | 0 EUR |
Market Cap | 123.49M EUR |
Beta (5Y Monthly) | 0.74636 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.13 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
1RC.SG Valuation Measures
Enterprise Value | 54.09M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.545224 |
Price/Book (mrq) | 1.2794117 |
Enterprise Value/Revenue | 1.991 |
Enterprise Value/EBITDA | -1.898 |
Trading Information
Creo Medical Group PLC Stock Price History
Beta (5Y Monthly) | 0.74636 |
52-Week Change | -70.74% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.08 EUR |
52 Week Low | 0.2 EUR |
50-Day Moving Average | 0.28 EUR |
200-Day Moving Average | 0.39 EUR |
1RC.SG Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 350.89M |
Float | 166.98M |
Short Ratio | N/A |
% Held by Insiders | 12.15% |
% Held by Institutions | 34.99% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -99.14% |
Operating Margin (ttm) | -113.20% |
Gross Margin | 48.29% |
EBITDA Margin | -104.90% |
Management Effectiveness
Return on Assets (ttm) | -21.85% |
Return on Equity (ttm) | -43.89% |
Income Statement
Revenue (ttm) | 27.17M EUR |
Revenue Per Share (ttm) | 0.15 EUR |
Quarterly Revenue Growth (yoy) | 10.40% |
Gross Profit (ttm) | N/A |
EBITDA | -28502000 EUR |
Net Income Avi to Common (ttm) | -26936000 EUR |
Diluted EPS (ttm) | -0.17 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 13.1M EUR |
Total Cash Per Share (mrq) | 0.07 EUR |
Total Debt (mrq) | 11.68M EUR |
Total Debt/Equity (mrq) | 23.65 EUR |
Current Ratio (mrq) | 1.927 |
Book Value Per Share (mrq) | 0.272 |
Cash Flow Statement
Operating Cash Flow (ttm) | -25054000 EUR |
Levered Free Cash Flow (ttm) | -23561876 EUR |
Profile of Creo Medical Group PLC
Country | Germany |
State | N/A |
City | Chepstow |
Address | Creo House |
ZIP | NP16 5UH |
Phone | 44 12 9160 6005 |
Website | https://creomedical.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 284 |
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.
Q&A For Creo Medical Group PLC Stock
What is a current 1RC.SG stock price?
Creo Medical Group PLC 1RC.SG stock price today per share is 0.39 EUR.
How to purchase Creo Medical Group PLC stock?
You can buy 1RC.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Creo Medical Group PLC?
The stock symbol or ticker of Creo Medical Group PLC is 1RC.SG.
Which industry does the Creo Medical Group PLC company belong to?
The Creo Medical Group PLC industry is Medical Devices.
How many shares does Creo Medical Group PLC have in circulation?
The max supply of Creo Medical Group PLC shares is 384.36M.
What is Creo Medical Group PLC Price to Earnings Ratio (PE Ratio)?
Creo Medical Group PLC PE Ratio is now.
What was Creo Medical Group PLC earnings per share over the trailing 12 months (TTM)?
Creo Medical Group PLC EPS is -0.13 EUR over the trailing 12 months.
Which sector does the Creo Medical Group PLC company belong to?
The Creo Medical Group PLC sector is Healthcare.